PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Preoperative Antihypertensive Medication in Relation to Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: A Meta-Analysis.

Abstract Background. We undertake a systematic review and meta-analysis to evaluate the effect of preoperative hypertension and preoperative antihypertensive medication to postoperative atrial fibrillation (POAF) in patients undergoing cardiac surgery. Methods. We searched PubMed, Embase, and Cochrane Library (from inception to March 2016) for eligible studies. The outcomes were the effects of preoperative hypertension, preoperative calcium antagonists regimen, preoperative ACE inhibitors regimen, and preoperative beta blocking agents regimen with POAF. We calculated pooled risk ratios (OR) and 95% CIs using random- or fixed-effects models. Results. Twenty-five trials involving 130087 patients were listed. Meta-analysis showed that the number of preoperative hypertension patients in POAF group was significantly higher (P < 0.05), while we found that there are no significant differences between two groups in Asia patients by subgroup analysis, which is in contrast to other outcomes. Compared with the Non-POAF group, the number of patients who used calcium antagonists and ACE inhibitors preoperatively in POAF group was significantly higher (P < 0.05). And we found that there were no significant differences between two groups of preoperative beta blocking agents used (P = 0.08). Conclusions. Preoperative hypertension and preoperative antihypertensive medication in patients undergoing cardiac operations seem to be associated with higher risk of POAF.
PMID
Related Publications

Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.

The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.

Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.

Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.

Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.

Authors

Mayor MeshTerms

Atrial Fibrillation

Cardiac Surgical Procedures

Hypertension

Preoperative Care

Keywords
Journal Title biomed research international
Publication Year Start




PMID- 28286753
OWN - NLM
STAT- MEDLINE
DA  - 20170313
DCOM- 20170317
LR  - 20170317
IS  - 2314-6141 (Electronic)
VI  - 2017
DP  - 2017
TI  - Preoperative Antihypertensive Medication in Relation to Postoperative Atrial
      Fibrillation in Patients Undergoing Cardiac Surgery: A Meta-Analysis.
PG  - 1203538
LID - 10.1155/2017/1203538 [doi]
AB  - Background. We undertake a systematic review and meta-analysis to evaluate the
      effect of preoperative hypertension and preoperative antihypertensive medication 
      to postoperative atrial fibrillation (POAF) in patients undergoing cardiac
      surgery. Methods. We searched PubMed, Embase, and Cochrane Library (from
      inception to March 2016) for eligible studies. The outcomes were the effects of
      preoperative hypertension, preoperative calcium antagonists regimen, preoperative
      ACE inhibitors regimen, and preoperative beta blocking agents regimen with POAF. 
      We calculated pooled risk ratios (OR) and 95% CIs using random- or fixed-effects 
      models. Results. Twenty-five trials involving 130087 patients were listed.
      Meta-analysis showed that the number of preoperative hypertension patients in
      POAF group was significantly higher (P &lt; 0.05), while we found that there are no 
      significant differences between two groups in Asia patients by subgroup analysis,
      which is in contrast to other outcomes. Compared with the Non-POAF group, the
      number of patients who used calcium antagonists and ACE inhibitors preoperatively
      in POAF group was significantly higher (P &lt; 0.05). And we found that there were
      no significant differences between two groups of preoperative beta blocking
      agents used (P = 0.08). Conclusions. Preoperative hypertension and preoperative
      antihypertensive medication in patients undergoing cardiac operations seem to be 
      associated with higher risk of POAF.
FAU - Zhou, Ai-Guo
AU  - Zhou AG
AD  - Department of Anesthesiology of the First People's Hospital of Changde City,
      Changde, Hunan, China.
FAU - Wang, Xian-Xue
AU  - Wang XX
AUID- ORCID: 0000-0001-7793-7991
AD  - Department of Anesthesiology of the First People's Hospital of Changde City,
      Changde, Hunan, China.
FAU - Pan, Dao-Bo
AU  - Pan DB
AUID- ORCID: 0000-0003-1969-7349
AD  - Department of Anesthesiology of the First People's Hospital of Changde City,
      Changde, Hunan, China.
FAU - Chen, An-Ji
AU  - Chen AJ
AD  - Department of Anesthesiology of the First People's Hospital of Changde City,
      Changde, Hunan, China.
FAU - Zhang, Xiong-Fei
AU  - Zhang XF
AD  - Department of Anesthesiology of the First People's Hospital of Changde City,
      Changde, Hunan, China.
FAU - Deng, Hui-Wei
AU  - Deng HW
AD  - Department of Anesthesiology of the First People's Hospital of Changde City,
      Changde, Hunan, China.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
DEP - 20170213
PL  - United States
TA  - Biomed Res Int
JT  - BioMed research international
JID - 101600173
RN  - 0 (Adrenergic beta-Antagonists)
RN  - 0 (Angiotensin-Converting Enzyme Inhibitors)
RN  - 0 (Calcium Channel Blockers)
SB  - IM
MH  - Adrenergic beta-Antagonists/*therapeutic use
MH  - Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
MH  - *Atrial Fibrillation/classification/physiopathology/therapy
MH  - Calcium Channel Blockers/*therapeutic use
MH  - *Cardiac Surgical Procedures
MH  - Clinical Trials as Topic
MH  - Female
MH  - Humans
MH  - *Hypertension/complications/physiopathology/therapy
MH  - Male
MH  - *Preoperative Care
PMC - PMC5327763
COI - The authors declare that they have no competing interests.
EDAT- 2017/03/14 06:00
MHDA- 2017/03/18 06:00
CRDT- 2017/03/14 06:00
PHST- 2016/05/24 [received]
PHST- 2016/10/08 [revised]
PHST- 2016/11/02 [accepted]
AID - 10.1155/2017/1203538 [doi]
PST - ppublish
SO  - Biomed Res Int. 2017;2017:1203538. doi: 10.1155/2017/1203538. Epub 2017 Feb 13.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>